FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152500592> ?p ?o ?g. }

• W2152500592 endingPage "1409" @default.
• W2152500592 startingPage "1399" @default.
• W2152500592 abstract "Anaemia is one of the major clinical characteristics of patients with chronic renal failure, and has a considerable effect on morbidity and mortality. Adequate dialysis is of paramount importance in correcting anaemia by removing small and medium-sized molecules, which may inhibit erythropoiesis. However, high-molecular-weight inhibitors cleared only by means of highly porous membranes have also been found in uraemic serum and it has been claimed from uncontrolled studies that high-flux dialysis could improve anaemia in haemodialysis patients.We therefore planned this multicentre randomized controlled trial with the aim of testing whether the use of a large-pore biocompatible membrane for a fixed 12-week follow-up improves anaemia in haemodialysis patients in comparison with the use of a conventional cellulose membrane. Eighty-four (5.3%) of a total of 1576 adult haemodialysed patients attending 13 Dialysis Units fulfilled the entry criteria and were randomly assigned to the experimental treatment (42 patients) or conventional treatment (42 patients).Haemoglobin levels increased non-significantly from 9.5+/-0.8 to 9.8+/-1.3 g/dl (dP=0. 069) in the population as a whole, with no significant difference between the two groups (P:=0.485). Erythropoietin therapy was given to 32/39 patients (82%) in the conventional group, and 26/35 (74%) in the experimental group (P:=0.783) with subcutaneous administration to 26/32 patients in conventional and to 23/26 patients in experimental group, P:=0.495. Dialysis dose (Kt/V) remained constant in both groups (from 1.30+/-0.17 to 1.33+/-0.20 in the conventional group and from 1.28+/-0.26 to 1.26+/-0.21 in the experimental group, P:=0.242). Median pre- and post-dialysis beta(2)-microglobulin levels remained constant in the conventional group (31.9 and 34.1 mg/dl at baseline) and decreased in the experimental group (pre-dialysis values from 31.1 to 24.7 mg/dl, P:=0.004 and post-dialysis values from 24.8 to 20.8 mg/dl, P:=0.002). Median erythropoietin doses were not different at baseline (70 IU/kg/week in conventional treatment and 90 IU/kg/week in experimental treatment, P:=0.628) and remained constant during follow-up (from 70 to 69 IU/kg/week in the conventional group and from 90 to 91 IU/kg/week in the experimental group, P:=0.410). Median erythropoietin plasma levels were in the normal range and remained constant (from 12.1 to 12.9 mU/ml in the conventional group and from 13.2 to 14.0 mU/ml in the experimental group, P:=0.550).This study showed no difference in haemoglobin level increase between patients treated for 3 months with a high-flux biocompatible membrane in comparison with those treated with a standard membrane. When patients are highly selected, adequately dialysed, and have no iron or vitamin depletion, the effect of a high-flux membrane is much less than might be expected from the results of uncontrolled studies." @default.
• W2152500592 created "2016-06-24" @default.
• W2152500592 creator A5011275095 @default.
• W2152500592 creator A5014136431 @default.
• W2152500592 creator A5017794721 @default.
• W2152500592 creator A5023590935 @default.
• W2152500592 creator A5028674790 @default.
• W2152500592 creator A5036926288 @default.
• W2152500592 creator A5040779038 @default.
• W2152500592 creator A5042922913 @default.
• W2152500592 creator A5044333817 @default.
• W2152500592 creator A5045593890 @default.
• W2152500592 creator A5046645888 @default.
• W2152500592 creator A5053616406 @default.
• W2152500592 creator A5059302289 @default.
• W2152500592 creator A5065296370 @default.
• W2152500592 creator A5071768099 @default.
• W2152500592 creator A5086650042 @default.
• W2152500592 date "2000-09-01" @default.
• W2152500592 modified "2023-09-23" @default.
• W2152500592 title "Effect of high‐flux dialysis on the anaemia of haemodialysis patients" @default.
• W2152500592 cites W1934757967 @default.
• W2152500592 cites W1947065742 @default.
• W2152500592 cites W1972226511 @default.
• W2152500592 cites W1974821040 @default.
• W2152500592 cites W1986604740 @default.
• W2152500592 cites W1989631524 @default.
• W2152500592 cites W2027119414 @default.
• W2152500592 cites W2050134441 @default.
• W2152500592 cites W2058178602 @default.
• W2152500592 cites W2086096523 @default.
• W2152500592 cites W2092665107 @default.
• W2152500592 cites W2126698345 @default.
• W2152500592 cites W2130864435 @default.
• W2152500592 cites W2156015398 @default.
• W2152500592 cites W2159901510 @default.
• W2152500592 cites W2213612481 @default.
• W2152500592 cites W2325384305 @default.
• W2152500592 cites W2325948200 @default.
• W2152500592 cites W2334894921 @default.
• W2152500592 cites W4213306416 @default.
• W2152500592 cites W4232849499 @default.
• W2152500592 cites W4252757239 @default.
• W2152500592 cites W92066299 @default.
• W2152500592 doi "https://doi.org/10.1093/ndt/15.9.1399" @default.
• W2152500592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10978398" @default.
• W2152500592 hasPublicationYear "2000" @default.
• W2152500592 type Work @default.
• W2152500592 sameAs 2152500592 @default.
• W2152500592 citedByCount "73" @default.
• W2152500592 countsByYear W21525005922012 @default.
• W2152500592 countsByYear W21525005922013 @default.
• W2152500592 countsByYear W21525005922014 @default.
• W2152500592 countsByYear W21525005922015 @default.
• W2152500592 countsByYear W21525005922017 @default.
• W2152500592 countsByYear W21525005922018 @default.
• W2152500592 countsByYear W21525005922019 @default.
• W2152500592 countsByYear W21525005922020 @default.
• W2152500592 countsByYear W21525005922021 @default.
• W2152500592 countsByYear W21525005922022 @default.
• W2152500592 crossrefType "journal-article" @default.
• W2152500592 hasAuthorship W2152500592A5011275095 @default.
• W2152500592 hasAuthorship W2152500592A5014136431 @default.
• W2152500592 hasAuthorship W2152500592A5017794721 @default.
• W2152500592 hasAuthorship W2152500592A5023590935 @default.
• W2152500592 hasAuthorship W2152500592A5028674790 @default.
• W2152500592 hasAuthorship W2152500592A5036926288 @default.
• W2152500592 hasAuthorship W2152500592A5040779038 @default.
• W2152500592 hasAuthorship W2152500592A5042922913 @default.
• W2152500592 hasAuthorship W2152500592A5044333817 @default.
• W2152500592 hasAuthorship W2152500592A5045593890 @default.
• W2152500592 hasAuthorship W2152500592A5046645888 @default.
• W2152500592 hasAuthorship W2152500592A5053616406 @default.
• W2152500592 hasAuthorship W2152500592A5059302289 @default.
• W2152500592 hasAuthorship W2152500592A5065296370 @default.
• W2152500592 hasAuthorship W2152500592A5071768099 @default.
• W2152500592 hasAuthorship W2152500592A5086650042 @default.
• W2152500592 hasBestOaLocation W21525005921 @default.
• W2152500592 hasConcept C126322002 @default.
• W2152500592 hasConcept C126894567 @default.
• W2152500592 hasConcept C138944611 @default.
• W2152500592 hasConcept C141071460 @default.
• W2152500592 hasConcept C168563851 @default.
• W2152500592 hasConcept C199091049 @default.
• W2152500592 hasConcept C2778063415 @default.
• W2152500592 hasConcept C2778248108 @default.
• W2152500592 hasConcept C2778534260 @default.
• W2152500592 hasConcept C2779056158 @default.
• W2152500592 hasConcept C2779978075 @default.
• W2152500592 hasConcept C2908647359 @default.
• W2152500592 hasConcept C41625074 @default.
• W2152500592 hasConcept C54355233 @default.
• W2152500592 hasConcept C71924100 @default.
• W2152500592 hasConcept C86803240 @default.
• W2152500592 hasConcept C90924648 @default.
• W2152500592 hasConcept C99454951 @default.
• W2152500592 hasConceptScore W2152500592C126322002 @default.
• W2152500592 hasConceptScore W2152500592C126894567 @default.

• next